Simplifying Global Compliance
FDAnews Device Daily Bulletin
Quest Diagnostics Announces Availability of TERC Test for Cervical Cancer
Sept. 4, 2012
Quest Diagnostics, the world’s leading provider of diagnostic testing, information and services, today announced the availability of a new laboratory test that identifies molecular changes to cervical cells that increase the likelihood a woman may develop cervical cancer.
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing